- Home
- ABUS vs PAXS Comparison
ABUS vs PAXS Comparison
Compare ABUS & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- PAXS
- Stock Information
- Founded
- ABUS N/A
- PAXS 2021
- Country
- ABUS United States
- PAXS United States
- Employees
- ABUS N/A
- PAXS N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- PAXS Investment Managers
- Sector
- ABUS Health Care
- PAXS Finance
- Exchange
- ABUS Nasdaq
- PAXS Nasdaq
- Market Cap
- ABUS 629.1M
- PAXS 722.0M
- IPO Year
- ABUS N/A
- PAXS N/A
- Fundamental
- Price
- ABUS $3.21
- PAXS $15.76
- Analyst Decision
- ABUS Strong Buy
- PAXS
- Analyst Count
- ABUS 4
- PAXS 0
- Target Price
- ABUS $5.50
- PAXS N/A
- AVG Volume (30 Days)
- ABUS 876.5K
- PAXS 195.0K
- Earning Date
- ABUS 02-27-2025
- PAXS 01-01-0001
- Dividend Yield
- ABUS N/A
- PAXS 11.72%
- EPS Growth
- ABUS N/A
- PAXS N/A
- EPS
- ABUS N/A
- PAXS N/A
- Revenue
- ABUS $6,742,000.00
- PAXS N/A
- Revenue This Year
- ABUS N/A
- PAXS N/A
- Revenue Next Year
- ABUS N/A
- PAXS N/A
- P/E Ratio
- ABUS N/A
- PAXS N/A
- Revenue Growth
- ABUS N/A
- PAXS N/A
- 52 Week Low
- ABUS $2.27
- PAXS $12.57
- 52 Week High
- ABUS $4.72
- PAXS $15.93
- Technical
- Relative Strength Index (RSI)
- ABUS 43.07
- PAXS 52.01
- Support Level
- ABUS $3.16
- PAXS $15.29
- Resistance Level
- ABUS $3.38
- PAXS $15.93
- Average True Range (ATR)
- ABUS 0.14
- PAXS 0.23
- MACD
- ABUS 0.00
- PAXS 0.04
- Stochastic Oscillator
- ABUS 19.51
- PAXS 80.46
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.